PRL and hyperprolactinemia: Our analysis supported that the increase in the treatment dose did not increase the incidence of hyperprolactinemia, which is also consistent with the conclusion of previous studies that “different doses of BNS did not cause a significant increase in blood prolactin levels” [23].